Tessema Belay, Moges Feleke, Habte Dereje, Hiruy Nebiyu, Yismaw Shewaye, Melkieneh Kassahun, Kassie Yewulsew, Girma Belaineh, Melese Muluken, Suarez Pedro G
Department of Medical Microbiology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Management Sciences for Health, Help Ethiopia Address the Low Performance of Tuberculosis (HEAL TB) Project, Addis Ababa, Ethiopia.
Ann Clin Microbiol Antimicrob. 2017 May 11;16(1):36. doi: 10.1186/s12941-017-0211-3.
Vitamin D is a fat-soluble vitamin that increases the immunity against tuberculosis (TB), decreases the re-activation of latent TB and reduces the severity of active TB disease. Epidemiological studies on the prevalence of vitamin D deficiency, and its association with TB showed inconsistent results in different countries. This study was aimed to determine the prevalence of vitamin D deficiency and its association with TB in Northwest Ethiopia.
A case-control study was conducted among smear positive pulmonary tuberculosis patients and their household contacts without symptoms suggestive of TB. Study participants were recruited at 11 TB diagnostic health facilities in North and South Gondar zones of Amhara region between May 2013 and April 2015. The spot-morning-spot sputum samples and 5 ml blood sample were collected prior to commencing TB treatment for the diagnosis of TB and serum vitamin D assay, respectively. The diagnosis of TB was performed using smear microscopy and GeneXpert. Serum vitamin D level was analyzed using VIDAS 25 OH Vitamin D Total testing kits (Biomerieux, Marcy I'Etoile, France) on mini VIDAS automated immunoassay platform. Vitamin D status was interpreted as deficient (<20 ng/ml), insufficient (20-29 ng/ml), sufficient (30-100 ng/ml) and potential toxicity (>100 ng/ml).
Of the total study participants, 134 (46.2%) were vitamin D deficient, and only 56 (19.3%) had sufficient vitamin D level. A total of 59 (61.5%) TB patients and 75 (38.7%) non TB controls were vitamin D deficient. Results of multivariate logistic regression analyses showed a significantly higher vitamin D deficiency among tuberculosis cases (p < 0.001), females (p = 0.002), and urban residents (p < 0.001) than their respective comparison groups. Moreover, age groups of 35-44 (p = 0.001), 45-54 (p = 0.003) and ≥55 (p = 0.001) years had significantly higher vitamin D deficiency compared with age group <15 years.
Vitamin D deficiency is highly prevalent among TB patients and non TB controls in Ethiopia where there is year round abundant sunshine. Study participants with tuberculosis, females, older age groups, and urban residents had significantly higher prevalence of vitamin D deficiency. These findings warrant further studies to investigate the role of vitamin D supplementation in the prevention and treatment of tuberculosis in high TB burden countries like Ethiopia.
维生素D是一种脂溶性维生素,可增强对结核病(TB)的免疫力,降低潜伏性结核的再激活率,并减轻活动性结核病的严重程度。关于维生素D缺乏症患病率及其与结核病关联的流行病学研究在不同国家显示出不一致的结果。本研究旨在确定埃塞俄比亚西北部维生素D缺乏症的患病率及其与结核病的关联。
在涂片阳性的肺结核患者及其无结核病症状的家庭接触者中进行了一项病例对照研究。2013年5月至2015年4月期间,在阿姆哈拉地区贡德尔南北区的11个结核病诊断卫生机构招募了研究参与者。分别在开始结核病治疗前采集即时-早晨-即时痰标本和5毫升血样,用于结核病诊断和血清维生素D检测。结核病诊断采用涂片显微镜检查和GeneXpert。血清维生素D水平使用VIDAS 25 OH维生素D总检测试剂盒(法国生物梅里埃公司,马西伊图瓦勒)在mini VIDAS自动免疫分析平台上进行分析。维生素D状态被解释为缺乏(<20 ng/ml)、不足(20 - 29 ng/ml)、充足(30 - 100 ng/ml)和潜在毒性(>100 ng/ml)。
在所有研究参与者中,134人(46.2%)维生素D缺乏,只有56人(19.3%)维生素D水平充足。共有59名(61.5%)结核病患者和75名(38.7%)非结核病对照者维生素D缺乏。多因素逻辑回归分析结果显示,结核病患者(p < 0.001)、女性(p = 0.002)和城市居民(p < 0.001)的维生素D缺乏率显著高于各自的对照组。此外,与<15岁年龄组相比,35 - 44岁(p = 0.001)、45 - 54岁(p = 0.003)和≥55岁(p = 0.001)年龄组的维生素D缺乏率显著更高。
在阳光常年充足的埃塞俄比亚,结核病患者和非结核病对照者中维生素D缺乏非常普遍。患有结核病的研究参与者、女性、老年人群体和城市居民的维生素D缺乏率显著更高。这些发现值得进一步研究,以调查补充维生素D在埃塞俄比亚等高结核病负担国家预防和治疗结核病中的作用。